Home/Filings/4/0001328143-21-000058
4//SEC Filing

MacPhee John A 4

Accession 0001328143-21-000058

CIK 0001328143other

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 4:15 PM ET

Size

7.3 KB

Accession

0001328143-21-000058

Insider Transaction Report

Form 4
Period: 2021-06-02
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-06-02+10,00010,000 total
    Exercise: $5.21From: 2022-06-02Exp: 2031-06-01Common Stock (10,000 underlying)
  • Award

    Common Stock

    2021-06-02+5,000202,000 total
Footnotes (2)
  • [F1]The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest on the one year anniversary of the grant date, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of such date.
  • [F2]The Option shares vest in full on the one year anniversary of the grant date, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of such date.

Issuer

Adamas Pharmaceuticals Inc

CIK 0001328143

Entity typeother

Related Parties

1
  • filerCIK 0001339976

Filing Metadata

Form type
4
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 4:15 PM ET
Size
7.3 KB